JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A2213 17-DMAG (Alvespimycin) HCl
1 Citation

Target: HSP90

Summary: Hsp90 inhibitor

≥26.2 mg/mL
A4056 AT13387

Target: HSP90

Summary: Hsp90 inhibitor

insoluble in H2O; ≥13.25 mg/mL
A4057 AUY922 (NVP-AUY922)
1 Citation

Target: HSP90

Summary: Potent Hsp90 inhibitor

≥23.27 mg/mL
A4058 BIIB021

Target: HSP90

Summary: Hsp90 inhibitor,selective and competitive

insoluble in EtOH; insoluble in H2O; ≥14.95 mg/mL
A4060 Geldanamycin
2 Citation

Summary: Hsp90 inhibitor,potent and specific

insoluble in EtOH; insoluble in H2O; ≥16.9 mg/mL
A4061 IPI-504 (Retaspimycin hydrochloride)
3 Citation

Target: HSP90

Summary: Hsp90 inhibitor,novel, potent,selective

≥26.1 mg/mL
A4062 KW-2478

Target: HSP90

Summary: Potent Hsp90 inhibitor, novel, non-ansamycin,

≥100 mg/mL
A4064 NVP-BEP800

Target: HSP90

Summary: Oral Hsp90β inhibitor, novel, fully synthetic
A4065 PF-04929113 (SNX-5422)

Target: HSP90

Summary: Hsp90 inhibitor,potent and selective

≥23.85 mg/mL
A4386 Elesclomol (STA-4783)
3 Citation

Summary: Oxidative stress/apoptosis inducer,potent and novel

insoluble in H2O; ≥20.15 mg/mL